Dexamethasone still beneficial for some inpatients with COVID-19

Early administration of dexamethasone is associated with significantly reduced odds of mortality or discharge to hospice for inpatients with COVID-19 receiving supplemental oxygen or mechanical ventilation (MV) and/or extracorporeal membrane oxygenation (ECMO), according to a study published online April 18 in JAMA Network Open.

Leave A Comment

Your email address will not be published. Required fields are marked *